Cencora

Krystal Haynes, Senior Director of Business Development, ICS, at Cencora, outlines the challenges facing cell and gene therapy manufacturers as they attempt to move products from clinical development to commercial availability.

Building effective pharmaceutical supply chain partnerships requires intentional investment in communication, internal alignment, and structured governance to navigate an increasingly volatile industry landscape.